112 results
8-K
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
the Placement Agent a cash fee of 7.0% of the aggregate gross proceeds raised in the Offering, and reimbursement of certain expenses.
In connection
8-K
EX-10.1
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
, inactions or services.
(e)The reimbursement, indemnity and contribution obligations of the Company set forth herein shall apply to any modification … directors or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution and reimbursement agreements
8-K
EX-10.2
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits
424B4
APVO
Aptevo Therapeutics Inc
12 Apr 24
Prospectus supplement with pricing info
5:23pm
counsel, that we have agreed to pay at the closing of the offering up to an aggregate expense reimbursement of $100,000.
Tail
In the event this offering
8-K
EX-10.2
q8300kp5 hjd0aqxak
9 Nov 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-10.1
9npf9bbm
4 Aug 23
Entry into a Material Definitive Agreement
6:51pm
8-K
wtrqfv
4 Aug 23
Entry into a Material Definitive Agreement
6:51pm